A Resolution designating the month of September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania. The resolution highlights the prevalence of prostate cancer, its risk factors, and the importance of awareness and screening. It emphasizes the need for men to consult with their physicians about prostate cancer screening options and the various tests used to detect the disease.
Key provisions
- Designates September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania.
- Acknowledges the prostate gland and its role in men's health.
- Highlights the increased risk of prostate cancer with age.
- States that 1 in 8 American men will get prostate cancer.
- Notes that 1 in 41 men will die from prostate cancer.
- Mentions the importance of early screening, particularly for those at higher risk.
- Lists two screening tests: prostate-specific antigen (PSA) test and digital rectal examination.
- Recommends consultation with a physician regarding prostate cancer screening.
Who is affected
- Men in Pennsylvania
- Families of men with prostate cancer
- Healthcare providers in Pennsylvania
Notable changes
- None – This resolution is a declaration of awareness, not a change to existing laws or regulations.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 2263 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Cosponsors
Benjamin Sanchez
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours